| 12378230 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan +8 more |
2025-08-05 |
|
| 12331041 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, Edward L. Conn, John M. Curto, David James Edmonds +7 more |
2025-06-17 |
|
| 12319669 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds +9 more |
2025-06-03 |
|
| 11858916 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, Edward L. Conn, John M. Curto, David James Edmonds +7 more |
2024-01-02 |
$249,725,000 |
| 11802121 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds +9 more |
2023-10-31 |
$284,263,000 |
| 11512070 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds +9 more |
2022-11-29 |
$2,104,375,000 |
| 10934279 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan +8 more |
2021-03-02 |
$1,471,575,000 |
| 10851081 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds +9 more |
2020-12-01 |
$390,003,000 |
| 10683281 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan +8 more |
2020-06-16 |
$1,092,312,000 |
| 10676465 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan +8 more |
2020-06-09 |
$602,135,000 |
| 10669259 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds +9 more |
2020-06-02 |
$395,652,000 |
| 10208019 |
GLP-1 receptor agonists and uses thereof |
Gary Erik Aspnes, Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds +9 more |
2019-02-19 |
$915,842,000 |
| 9278953 |
Antagonists of prostaglandin EP3 receptor |
Kevin Bahnck, David James Edmonds, Kentaro Futatsugi, Esther Cheng Yin Lee, Elnaz Menhaji-Klotz +1 more |
2016-03-08 |
$658,400,000 |
| 5618844 |
Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
Madhusudhan Reddy Gowravaram, Jeffrey W. Johnson, Ewell Cook, Robert Wahl, Bruce E. Tomczuk +1 more |
1997-04-08 |
|
| 5514716 |
Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
Madhusudhan Reddy Gowravaram, Jeffrey W. Johnson, Ewell Cook, Robert Wahl, Bruce E. Tomczuk +1 more |
1996-05-07 |
$8,929,000 |
